Internationally Renowned Medical Physics Expert Professor Eric Ford Visits Raycision

Raycision recently welcomed a distinguished American guest, Professor Eric Ford, for an exclusive visit to its newly established office and R&D base. This visit marks a significant leap forward in the company's high-end products entering developed markets and represents a new step in the company's unwavering commitment to implementing its product internationalization strategy.

Professor Eric Ford is the Head of the Physics Division in the Department of Radiation Oncology at the prestigious University of Washington. He is a Fellow of the American Association of Physicists in Medicine (AAPM) and the American Society for Radiation Oncology (ASTRO), as well as an internationally renowned medical physicist and educator. He holds a distinguished position and academic reputation in the fields of precision radiotherapy and medical imaging. The company's Chief Scientist and management team warmly received Professor Ford and provided a detailed introduction to the company's development achievements and technological innovations. At the company's R&D base, Professor Ford conducted a comprehensive inspection of the R&D facilities, gained an in-depth understanding of the technical features of the company's products, and personally experienced the product functionalities. He was highly impressed by the innovation and performance advantages of the company's products, believing that the advanced technology will provide strong support for academic peers in cutting-edge research and high-tech fields, with broad application prospects. He highly endorsed the company's strategic initiative to consistently target high-end international markets and offered valuable suggestions based on the differentiated characteristics of the European and American markets.

Professor Eric Ford's visit to the company successfully achieved the predetermined cooperation goals. The two parties not only completed discussions on deep technical cooperation and product export applications but also reached important consensus on overseas joint R&D and technology promotion, injecting new momentum into the company's technological innovation. Taking this opportunity, the company will accelerate its internationalization process, leveraging its superior products and outstanding technology to continuously advance the development of international precision biomedical sciences.